[Do the Directorate of Health’s guidelines adhere to international standards for trustworthy clinical practice?].

Tidsskr Nor Laegeforen

Klinisk effektforskning, Institutt for helse og samfunn, Universitetet i Oslo, og, Avdeling for transplantasjonsmedisin, Oslo universitetssykehus, og, Institutt for klinisk medisin, UiT Norges arktiske universitet.

Published: October 2023

Background: The Norwegian Directorate of Health produces national clinical guidelines for the health service, and the development of guidelines must follow international standards for trustworthy clinical practice. We investigated whether the standards are being adhered to.

Material And Method: We used the National Guideline Clearinghouse Extent Adherence to Trustworthy Standards Instrument (NEATS) as the scoring tool and assessed a randomly selected chapter from national clinical guidelines that were published or updated during the period 2013 to January 2022. NEATS has 15 domain items; three are assessed with the response alternatives Yes/No/Not known, and twelve are assessed on a Likert scale from 1 to 5, where 1 corresponds to very low trustworthiness and 5 to very high trustworthiness. The assessments were made individually by two authors. Inter-rater reliability was assessed with exact or close reliability, and Cohen's kappa coefficient.

Results: We included 60 relevant guidelines. For nine of the twelve NEATS domain items assessed using the Likert scale, there was very low or low adherence to standards for trustworthy clinical guidelines (median score 1 or 2). The domain items with the lowest score (median score 1) were 'The study selection', 'Description of the studies and the results', 'Rating the strength of recommendations' and 'External review'. The domain item with the highest score was 'Specific and unambiguous articulation of recommendations' (median score 4).

Interpretation: The majority of the national clinical guidelines had low adherence to the standards for trustworthy clinical guidelines assessed using the NEATS scoring tool.

Download full-text PDF

Source
http://dx.doi.org/10.4045/tidsskr.23.0110DOI Listing

Publication Analysis

Top Keywords

clinical guidelines
20
standards trustworthy
16
trustworthy clinical
16
national clinical
12
domain items
12
median score
12
guidelines
8
international standards
8
neats scoring
8
scoring tool
8

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

STEM Neurology & Neuropsychological0 Research Group Egypt (SNRGE), Port Said, Port Said, Egypt.

Background: Donepezil, an acetylcholinesterase inhibitor (AChEI), is an FDA-approved drug to treat these neurodegenerative diseases, e.g., Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI).

View Article and Find Full Text PDF

Real-world data on the uptake, effectiveness and safety of new diagnostics and disease-modifying (DMT) treatments for Alzheimer's Disease (AD) are imperative. This can be achieved through patient registries. A major challenge is how to embed registry data capture into routine clinical practice.

View Article and Find Full Text PDF

Dementia Care Research and Psychosocial Factors.

Alzheimers Dement

December 2024

Department of Psychiatry and Psychotherapy, Medical Faculty, University of Cologne, Cologne, Germany.

Background: Due to further development of diagnostic methods of early-stage diagnosis of Alzheimer's disease (AD) and new disease-modifying treatment options that require early diagnosis, a new focus on predictive and preventive medicine arises. With progress in AD dementia risk estimation, guidelines for counseling, considering individual aspects of those affected, are becoming more important. As part of the trinational project PreTAD (The Predictive Turn in Alzheimer's Disease: Ethical, Clinical, Linguistic and Legal Aspects) anticipated effects of AD dementia risk estimation for first-degree relatives of people with AD dementia are evaluated.

View Article and Find Full Text PDF

Dementia Care Research and Psychosocial Factors.

Alzheimers Dement

December 2024

University of Georgia, College of Pharmacy, Athens, GA, USA.

Background: Reducing chronic inflammation has been linked to anti-inflammatory foods and may be implicated in treating Alzheimer's disease (AD). Plants produce antioxidants, such as phytochemicals, that appear to reduce the incidence of chronic inflammatory diseases. Phytochemicals may include active substances like polyphenols.

View Article and Find Full Text PDF

Background: The cognitive reserve (CR) theory seeks to explain the mismatch often reported between brain damage and its clinical expression. Unlike most previous studies that focused on individuals with memory deterioration before the diagnosis of Alzheimer's disease (AD), the present study examined the late stages of the disease. The study sought to confirm the hypothesis that patients with higher CR are diagnosed later and decline faster than those with lower CR because their brain pathology is more severe.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!